Posted in | News

Skanska Makes Investment in Phase I of High Five Office Project in Cracow, Poland

Skanska invests EUR 48 M, about SEK 450 M, in phase I of High Five, an office project located in Cracow, Poland. The first phase, consisting of two office buildings will offer a total leasable area of around 23,000 square meters. Each building will comprise of six storeys above ground and two below ground for parking lots.

High Five will be Skanska’s largest office development in Cracow. The complex will comprise five office buildings with a total leasable area of around 70,000 square meters. The project is expected to receive LEED Gold certification.

Construction of the first phase is due to start in March 2016 and is scheduled for completion in the fourth quarter of 2017.

Skanska Commercial Development Europe initiates and develops office property projects. The company’s operations are concentrated in the metropolitan areas of the Czech Republic, Hungary, Romania and Poland and are conducted in four local units: Skanska Property Czech Republic, Skanska Property Hungary, Skanska Romania and Skanska Property Poland.

Skanska AB may be required to disclose the information provided herein pursuant to the Securities Markets Act. Skanska is one of the world’s leading project development and construction groups with expertise in construction, development of commercial and residential premises, and public-private partnerships projects. Based on its global green experience, Skanska aims to be the clients' first choice for Green solutions. The Group currently has 43,100 employees in selected home markets in Europe and North America. Skanska's sales in 2015 totaled SEK 155 billion.

This information was brought to you by Cision http://news.cision.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.